跳至主要内容
临床试验/NCT01254097
NCT01254097已完成不适用

Feasibility Study of Probiotics in Primary Care

Milton S. Hershey Medical Center1 个研究点 分布在 1 个国家目标入组 51 人开始时间: 2011年3月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
51
试验地点
1
主要终点
Rate of antibiotic associated diarrhea

研究概览

简要总结

Antibiotics are lifesaving medicines and generally safe, yet unwanted side effects are common. While destroying illness-causing 'bad' bacteria, antibiotics can upset the protective 'good' bacteria in the body. This research will test if taking a probiotic with prescribed antibiotics will decrease the chance of having bothersome antibiotic-associated side effects.

详细描述

Objectives Several studies have demonstrated that probiotics can be helpful in preventing antibiotic-associated diarrhoea in hospitalized patients. However, the extent to which probiotics may benefit healthy adults taking a course of antibiotics has not been investigated in primary care. Furthermore, patient willingness to take a probiotic supplement concomitantly with antibiotics has not been explored. We aimed to conduct an exploratory study using probiotics in adults requiring an acute course of antibiotic therapy.

Methods Patients prescribed antibiotics for treatment of acute infections in an outpatient family practice setting were randomized to receive either a probiotic or placebo concurrently. Patients completed adherence diaries and daily symptom checklists to assess gastrointestinal and vaginal (women) symptoms and collect information about adherence.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Single Group
主要目的
Prevention
盲法
Double (Participant, Investigator)

入排标准

年龄范围
18 Years 至 79 Years(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •adults 18 - 79 years of age with infection requiring an oral antibiotic.
  • •Must be able to be contacted via telephone.

排除标准

  • •pregnancy,
  • •breast-feeding,
  • •those receiving tube feeding,
  • •those with diarrhea as a current symptom of present illness, and pre-existing illnesses that contribute to diarrhea such as inflammatory bowel disease,
  • •irritable bowel syndrome, colitis or celiac disease.
  • •Those undergoing active cancer treatments with chemotherapeutic or radiation therapy,
  • •immunocompromised persons,
  • •history of cardiac valvular disease,
  • •those taking a laxative or stool softener on a daily basis, as well as
  • •persons treated with an antibiotic in the previous 60 days,
  • •new antibiotic prescription that exceeds a 10 day course, or regular use of a probiotic within the previous three weeks (including daily ingestion of yogurt).

研究组 & 干预措施

Placebo

Placebo Comparator

Participants are provided in double blinded fashion, Look alike placebo given to take with antibiotics prescribed by their provider.

干预措施: Probiotic (Dietary Supplement)

Probiotic

Placebo Comparator

Participants are provided in double blinded fashion, probiotic given to take with antibiotics prescribed by their provider.

干预措施: Probiotic (Dietary Supplement)

结局指标

主要结局

Rate of antibiotic associated diarrhea

时间窗: two weeks after start of antibiotics

Groups will be compared based on rates of antibiotic associated diarrhea, symptoms developing in the two week window of when antibiotics are started.

次要结局

  • Participant knowledge of probiotics(At participant recruitment)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

William Curry

Professor, Family and Community Medicine

Milton S. Hershey Medical Center

研究点 (1)

Loading locations...

相似试验